Brazil
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.11 B
|
Dec. 31, 2023 | USD 4.80 | 0.53% |
|
Brazil |
|
2 |
USD 454.20 M
|
Dec. 31, 2023 | USD 0.31 | -1.64% |
|
Brazil |
|
3 |
USD 349.92 M
|
Dec. 31, 2023 | USD 2.04 | 0.87% |
|
Brazil |
|
4 |
USD 227.38 M
|
Dec. 31, 2023 | USD 16.15 | -4.10% |
|
Brazil |
|
5 |
USD 84.45 M
|
Dec. 31, 2023 | USD 2.21 | -0.40% |
|
Brazil |
|
6 |
USD 31.83 M
|
Dec. 31, 2023 | USD 1.95 | -3.23% |
|
Brazil |
|
7 |
USD 5.49 M
|
Dec. 31, 2023 | USD 1.97 | 2.04% |
|
Brazil |
|
8 |
USD -11.18 M
|
Dec. 31, 2023 | USD 1.66 | 0.01% |
|
Brazil |
The Biotechnology company in Brazil with the highest EBITDA is Rede D'Or São Luiz S.A. (São Paulo Stock Exchange: RDOR3.SA) at USD 2.11 B.
The Biotechnology company in Brazil with the lowest EBITDA is Biomm S.A. (São Paulo Stock Exchange: BIOM3.SA) at USD -11.18 M.
The top 10 Biotechnology companies in Brazil by EBITDA are Rede D'Or São Luiz S.A., Diagnósticos da América S.A., Fleury S.A., Afya Limited, Blau Farmacêutica S.A., Centro de Imagem Diagnósticos S.A., Baumer S.A. and Biomm S.A..
The bottom 10 Biotechnology companies in Brazil by EBITDA are Biomm S.A., Baumer S.A., Centro de Imagem Diagnósticos S.A., Blau Farmacêutica S.A., Afya Limited, Fleury S.A., Diagnósticos da América S.A. and Rede D'Or São Luiz S.A..